This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Psoriasis  • Dermatology, Other  • Alert me on articles by topic

Arch Dermatol. 2000;136:1547-1549.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis
Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CME
BMJ. 2000;320:963-967

Ashcroft et al performed a quantitative systematic review to assess the comparative efficacy and tolerability of topical calcipotriol in the treatment of mild to moderate chronic plaque psoriasis. The authors searched MEDLINE, EMBASE, the Cochrane Collaboration Controlled Clinical Trials Registry, and BIDS index to scientific and technical proceedings using relevant keywords and contacted the manufacturers of calcipotriol.

Only randomized controlled trials of calcipotriol were included, and only patients with chronic plaque psoriasis treated with 0.005% calcipotriol cream or ointment were eligible for inclusion. As in all Cochrane systematic reviews, trial eligibility was determined and data extracted independently by 2 authors.

The efficacy was estimated using the following outcome measures: (1) the proportion of patients in the calcipotriol group achieving at least marked improvement . . . [Full Text of this Article]

Editor's Comment

RELATED ARTICLE

Combination Regimens of Topical Calcipotriene in Chronic Plaque Psoriasis: Systematic Review of Efficacy and Tolerability
Darren M. Ashcroft, Alain Li Wan Po, Hywel C. Williams, and Christopher E. M. Griffiths
Arch Dermatol. 2000;136(12):1536-1543.
ABSTRACT | FULL TEXT